| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |